BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22120721)

  • 1. Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression.
    Mao L; Ding J; Perdue A; Yang L; Zha Y; Ren M; Huang S; Cui H; Ding HF
    Oncogene; 2012 Aug; 31(33):3785-95. PubMed ID: 22120721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYCN and MYC regulate tumor proliferation and tumorigenesis directly through BMI1 in human neuroblastomas.
    Huang R; Cheung NK; Vider J; Cheung IY; Gerald WL; Tickoo SK; Holland EC; Blasberg RG
    FASEB J; 2011 Dec; 25(12):4138-49. PubMed ID: 21856782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.
    Ochiai H; Takenobu H; Nakagawa A; Yamaguchi Y; Kimura M; Ohira M; Okimoto Y; Fujimura Y; Koseki H; Kohno Y; Nakagawara A; Kamijo T
    Oncogene; 2010 May; 29(18):2681-90. PubMed ID: 20190806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma.
    Gebauer S; Yu AL; Omura-Minamisawa M; Batova A; Diccianni MB
    Genes Chromosomes Cancer; 2004 Dec; 41(4):297-308. PubMed ID: 15390183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
    Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
    Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.
    Calao M; Sekyere EO; Cui HJ; Cheung BB; Thomas WD; Keating J; Chen JB; Raif A; Jankowski K; Davies NP; Bekkum MV; Chen B; Tan O; Ellis T; Norris MD; Haber M; Kim ES; Shohet JM; Trahair TN; Liu T; Wainwright BJ; Ding HF; Marshall GM
    Oncogene; 2013 Aug; 32(31):3616-26. PubMed ID: 22907436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
    Xu Y; Sengupta T; Kukreja L; Minella AC
    J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.
    Isobe T; Hattori T; Kitagawa K; Uchida C; Kotake Y; Kosugi I; Oda T; Kitagawa M
    J Biol Chem; 2009 Oct; 284(41):27766-27779. PubMed ID: 19679664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skp1-Cullin-F-box (SCF)-type ubiquitin ligase FBXW7 negatively regulates spermatogonial stem cell self-renewal.
    Kanatsu-Shinohara M; Onoyama I; Nakayama KI; Shinohara T
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8826-31. PubMed ID: 24879440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.
    Zhang XW; Sheng YP; Li Q; Qin W; Lu YW; Cheng YF; Liu BY; Zhang FC; Li J; Dimri GP; Guo WJ
    Mol Cancer; 2010 Feb; 9():40. PubMed ID: 20170541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fbw7α and Fbw7γ collaborate to shuttle cyclin E1 into the nucleolus for multiubiquitylation.
    Bhaskaran N; van Drogen F; Ng HF; Kumar R; Ekholm-Reed S; Peter M; Sangfelt O; Reed SI
    Mol Cell Biol; 2013 Jan; 33(1):85-97. PubMed ID: 23109421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer.
    Becker M; Korn C; Sienerth AR; Voswinckel R; Luetkenhaus K; Ceteci F; Rapp UR
    PLoS One; 2009; 4(1):e4230. PubMed ID: 19156217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-25 Inhibits Cell Apoptosis of Human Gastric Adenocarcinoma Cell Line AGS via Regulating CCNE1 and MYC.
    Zhang Y; Peng Z; Zhao Y; Chen L
    Med Sci Monit; 2016 Apr; 22():1415-20. PubMed ID: 27120728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells.
    Chagraoui J; Niessen SL; Lessard J; Girard S; Coulombe P; Sauvageau M; Meloche S; Sauvageau G
    Genes Dev; 2006 Aug; 20(15):2110-20. PubMed ID: 16882984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
    Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
    Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas.
    Nowak K; Kerl K; Fehr D; Kramps C; Gessner C; Killmer K; Samans B; Berwanger B; Christiansen H; Lutz W
    Nucleic Acids Res; 2006; 34(6):1745-54. PubMed ID: 16582100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
    Caldon CE; Sergio CM; Sutherland RL; Musgrove EA
    Cell Cycle; 2013 Feb; 12(4):596-605. PubMed ID: 23324394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bmi1 is required for Hedgehog pathway-driven medulloblastoma expansion.
    Michael LE; Westerman BA; Ermilov AN; Wang A; Ferris J; Liu J; Blom M; Ellison DW; van Lohuizen M; Dlugosz AA
    Neoplasia; 2008 Dec; 10(12):1343-9, 5p following 1349. PubMed ID: 19048113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor.
    Williams RD; Al-Saadi R; Chagtai T; Popov S; Messahel B; Sebire N; Gessler M; Wegert J; Graf N; Leuschner I; Hubank M; Jones C; Vujanic G; Pritchard-Jones K; ;
    Clin Cancer Res; 2010 Apr; 16(7):2036-45. PubMed ID: 20332316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL.
    van Galen JC; Muris JJ; Oudejans JJ; Vos W; Giroth CP; Ossenkoppele GJ; Otte AP; Raaphorst FM; Meijer CJ
    J Clin Pathol; 2007 Feb; 60(2):167-72. PubMed ID: 16837630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.